Because further studies revealed that some RA patients may be not responding or intolerant to anti-TNF therapy a monoclonal antibody against CD20+ B cells were used to cause transient depletion of B cells which are known to stimulate MMPs production by synovial cells [5, 10, 11]. The gene discussed is TNF; the disease is rheumatoid arthritis.